Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 PneumoniaJane A. O’Halloran, Michael A. Proschan, Matthew W. McCarthy et al.|JAMA|2023Cited by 67
Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised PatientsEssack Mitha, Loreta Vareikiene, Gergely Kriván et al.|Infectious Diseases and Therapy|2019Cited by 26